380 related articles for article (PubMed ID: 32387695)
21. Mechanisms of vaccine adjuvanticity at mucosal surfaces.
Foss DL; Murtaugh MP
Anim Health Res Rev; 2000 Jun; 1(1):3-24. PubMed ID: 11706842
[TBL] [Abstract][Full Text] [Related]
22. Dendritic cell-targeting DNA-based nasal adjuvants for protective mucosal immunity to Streptococcus pneumoniae.
Kataoka K; Fukuyama Y; Briles DE; Miyake T; Fujihashi K
Microbiol Immunol; 2017 Jun; 61(6):195-205. PubMed ID: 28463465
[TBL] [Abstract][Full Text] [Related]
23. Subunit-based mucosal vaccine delivery systems for pulmonary delivery - Are they feasible?
Marasini N; Kaminskas LM
Drug Dev Ind Pharm; 2019 Jun; 45(6):882-894. PubMed ID: 30767591
[TBL] [Abstract][Full Text] [Related]
24. Mucosal vaccines: a paradigm shift in the development of mucosal adjuvants and delivery vehicles.
Srivastava A; Gowda DV; Madhunapantula SV; Shinde CG; Iyer M
APMIS; 2015 Apr; 123(4):275-88. PubMed ID: 25630573
[TBL] [Abstract][Full Text] [Related]
25. Recent developments in adjuvants for vaccines against infectious diseases.
O'Hagan DT; MacKichan ML; Singh M
Biomol Eng; 2001 Oct; 18(3):69-85. PubMed ID: 11566599
[TBL] [Abstract][Full Text] [Related]
26. Mucosal vaccines: recent progress in understanding the natural barriers.
Borges O; Lebre F; Bento D; Borchard G; Junginger HE
Pharm Res; 2010 Feb; 27(2):211-23. PubMed ID: 19953309
[TBL] [Abstract][Full Text] [Related]
27. Inducing Mucosal IgA: A Challenge for Vaccine Adjuvants and Delivery Systems.
Boyaka PN
J Immunol; 2017 Jul; 199(1):9-16. PubMed ID: 28630108
[TBL] [Abstract][Full Text] [Related]
28. Chitosan-based Nanoparticles in Mucosal Vaccine Delivery.
Mehrabi M; Montazeri H; Mohamadpour Dounighi N; Rashti A; Vakili-Ghartavol R
Arch Razi Inst; 2018 Sep; 73(3):165-176. PubMed ID: 30280836
[TBL] [Abstract][Full Text] [Related]
29. Nanocarriers: a versatile approach for mucosal vaccine delivery.
Mody N; Sharma R; Agrawal U; Vyas SP
Ther Deliv; 2015 Feb; 6(2):231-45. PubMed ID: 25690089
[TBL] [Abstract][Full Text] [Related]
30. Advances and Potential Applications of Chitosan Nanoparticles as a Delivery Carrier for the Mucosal Immunity of Vaccine.
Li D; Fu D; Kang H; Rong G; Jin Z; Wang X; Zhao K
Curr Drug Deliv; 2017; 14(1):27-35. PubMed ID: 27494157
[TBL] [Abstract][Full Text] [Related]
31. Biocompatible Mater Constructed Microneedle Arrays as a Novel Vaccine Adjuvant- Delivery System for Cutaneous and Mucosal Vaccination.
Wang T; Wang N
Curr Pharm Des; 2015; 21(36):5245-55. PubMed ID: 26412356
[TBL] [Abstract][Full Text] [Related]
32. New advances in mucosal vaccination.
Ranasinghe C
Immunol Lett; 2014 Oct; 161(2):204-6. PubMed ID: 24462961
[TBL] [Abstract][Full Text] [Related]
33. Jump-starting the immune system: prime-boosting comes of age.
Woodland DL
Trends Immunol; 2004 Feb; 25(2):98-104. PubMed ID: 15102369
[TBL] [Abstract][Full Text] [Related]
34. Recent advances in mucosal vaccine development.
Chen H
J Control Release; 2000 Jul; 67(2-3):117-28. PubMed ID: 10825547
[TBL] [Abstract][Full Text] [Related]
35. Surface modified nanoparticulate carrier constructs for oral mucosal vaccine delivery.
Mishra N; Singh D; Sharma S; Baldi A
Curr Drug Deliv; 2014; 11(6):729-43. PubMed ID: 25007830
[TBL] [Abstract][Full Text] [Related]
36. Archaeal lipid mucosal vaccine adjuvant and delivery system.
Patel GB; Chen W
Expert Rev Vaccines; 2010 Apr; 9(4):431-40. PubMed ID: 20370552
[TBL] [Abstract][Full Text] [Related]
37. Bioadhesive delivery systems for mucosal vaccine delivery.
Baudner BC; O'Hagan DT
J Drug Target; 2010 Dec; 18(10):752-70. PubMed ID: 21039314
[TBL] [Abstract][Full Text] [Related]
38. Mucosal Vaccine Development Based on Liposome Technology.
Bernasconi V; Norling K; Bally M; Höök F; Lycke NY
J Immunol Res; 2016; 2016():5482087. PubMed ID: 28127567
[TBL] [Abstract][Full Text] [Related]
39. Mucosal immunity: overcoming the barrier for induction of proximal responses.
McKenzie BS; Brady JL; Lew AM
Immunol Res; 2004; 30(1):35-71. PubMed ID: 15258310
[TBL] [Abstract][Full Text] [Related]
40. Generation of improved mucosal vaccines by induction of innate immunity.
Lavelle EC
Cell Mol Life Sci; 2005 Dec; 62(23):2750-70. PubMed ID: 16237500
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]